The continuing uncertainty about cancer risk in inflammatory bowel disease

doi:10.1136/gutjnl-2015-311003

Review

. 2016 Jun;65(6):889-93.

doi: 10.1136/gutjnl-2015-311003. Epub 2016 Mar 23.

The continuing uncertainty about cancer risk in inflammatory bowel disease

Hans-Olov Adami¹, Michael Bretthauer², Louise Emilsson², Miguel A Hernán³, Mette Kalager², Jonas F Ludvigsson⁴, Anders Ekbom⁵

Affiliations

¹ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
² Institute of Health and Society, University of Oslo, Oslo, Norway.
³ Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
⁴ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Medicine Solna, Clinical Epidemiology Unit T2, Karolinska Institutet, Stockholm, Sweden.

PMID: 27008845
PMCID: PMC5226357
DOI: 10.1136/gutjnl-2015-311003

Review

The continuing uncertainty about cancer risk in inflammatory bowel disease

Hans-Olov Adami et al. Gut. 2016 Jun.

. 2016 Jun;65(6):889-93.

doi: 10.1136/gutjnl-2015-311003. Epub 2016 Mar 23.

Authors

Hans-Olov Adami¹, Michael Bretthauer², Louise Emilsson², Miguel A Hernán³, Mette Kalager², Jonas F Ludvigsson⁴, Anders Ekbom⁵

Affiliations

¹ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
² Institute of Health and Society, University of Oslo, Oslo, Norway.
³ Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
⁴ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁵ Department of Medicine Solna, Clinical Epidemiology Unit T2, Karolinska Institutet, Stockholm, Sweden.

PMID: 27008845
PMCID: PMC5226357
DOI: 10.1136/gutjnl-2015-311003

No abstract available

Keywords: COLORECTAL CANCER; CROHN'S DISEASE; ULCERATIVE COLITIS.

PubMed Disclaimer

Cited by

Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.
Dulai PS, Sandborn WJ, Gupta S. Dulai PS, et al. Cancer Prev Res (Phila). 2016 Dec;9(12):887-894. doi: 10.1158/1940-6207.CAPR-16-0124. Epub 2016 Sep 27. Cancer Prev Res (Phila). 2016. PMID: 27679553 Free PMC article. Review.
Colorectal Cancer in County Durham-England a Clinical and Statistical Study.
Ilie DS, Şerbanescu MS, Ionovici N, Busuioc CJ, Mogoantă L. Ilie DS, et al. Curr Health Sci J. 2021 Jul-Sep;47(3):338-347. doi: 10.12865/CHSJ.47.03.02. Epub 2021 Sep 30. Curr Health Sci J. 2021. PMID: 35003764 Free PMC article.
MTG16 is a tumor suppressor in colitis-associated carcinoma.
McDonough EM, Barrett CW, Parang B, Mittal MK, Smith JJ, Bradley AM, Choksi YA, Coburn LA, Short SP, Thompson JJ, Zhang B, Poindexter SV, Fischer MA, Chen X, Li J, Revetta FL, Naik R, Washington MK, Rosen MJ, Hiebert SW, Wilson KT, Williams CS. McDonough EM, et al. JCI Insight. 2017 Aug 17;2(16):e78210. doi: 10.1172/jci.insight.78210. eCollection 2017 Aug 17. JCI Insight. 2017. PMID: 28814670 Free PMC article.
Small Bowel Carcinoma in the Setting of Inflammatory Bowel Disease.
Bhatt H, Mathis KL. Bhatt H, et al. Clin Colon Rectal Surg. 2023 Mar 15;37(1):46-52. doi: 10.1055/s-0043-1762929. eCollection 2024 Jan. Clin Colon Rectal Surg. 2023. PMID: 38188070 Free PMC article. Review.
From Colitis to Cancer: An Evolutionary Trajectory That Merges Maths and Biology.
Al Bakir I, Curtius K, Graham TA. Al Bakir I, et al. Front Immunol. 2018 Oct 16;9:2368. doi: 10.3389/fimmu.2018.02368. eCollection 2018. Front Immunol. 2018. PMID: 30386335 Free PMC article. Review.

See all "Cited by" articles

References

1. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228–33. - PubMed
1. Askling J, Dickman PW, Karlen P, et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet. 2001;357:262–6. - PubMed
1. Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372:1441–52. - PubMed
1. Castano-Milla C, Chaparro M, Gisbert JP. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther. 2014;39:645–59. - PubMed
1. Lutgens MW, van Oijen MG, van der Heijden GJ, et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013;19:789–99. - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228–33. - PubMed

[2] Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228–33. - PubMed

[3] Askling J, Dickman PW, Karlen P, et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet. 2001;357:262–6. - PubMed

[4] Askling J, Dickman PW, Karlen P, et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet. 2001;357:262–6. - PubMed

[5] Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372:1441–52. - PubMed

[6] Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372:1441–52. - PubMed

[7] Castano-Milla C, Chaparro M, Gisbert JP. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther. 2014;39:645–59. - PubMed

[8] Castano-Milla C, Chaparro M, Gisbert JP. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther. 2014;39:645–59. - PubMed

[9] Lutgens MW, van Oijen MG, van der Heijden GJ, et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013;19:789–99. - PubMed

[10] Lutgens MW, van Oijen MG, van der Heijden GJ, et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013;19:789–99. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The continuing uncertainty about cancer risk in inflammatory bowel disease

Affiliations

The continuing uncertainty about cancer risk in inflammatory bowel disease

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical